US FDA approves ILUMYA for adults with active psoriatic arthritis Approval expands the drug’s use beyond moderate-to-severe plaque […]
Breaking News / Business / Maharashtra / Mumbai / Pharma / South Africa
Sun Pharma wins South Africa nod for generic Semaglutide, expands global diabetes footprint
Receives regulatory approval to manufacture and market once-weekly injectable for Type 2 diabetes South Africa becomes second market […]
Ayush / Breaking News / Business / Health & Environment / Hospitals / Human Interest / Launchpad / Mumbai / National / Pharma
Not just a doctor, but a second chance: Shreyas Iyer leads Sun Pharma’s #SecondBirthDate Salute to India’s healthcare heroes
National Doctors’ Day campaign celebrates the life-saving role of doctors through stories of resilience and recovery Indian T20I […]
America / Breaking News / Business / Mumbai / National / Pharma
Sun Pharma gets FDA nod for enhanced Unloxcyt™ Label
Long-term data show stronger, more durable responses in advanced skin cancer First and only PD-L1 inhibitor for aCSCC […]
Bengaluru / Breaking News / Business / Hospitals / Joint Venture/Partnerships / Karnataka / National / Pharma
Astrazeneca & Sun Pharma join forces to expand access to hyperkalaemia therapy in India
Partnership to accelerate nationwide availability of Sodium Zirconium Cyclosilicate (SZC) Dual-brand strategy—Lokelma® and Gimliand®—to boost adoption for CKD […]
Breaking News / Business / Health & Environment / Hospitals / Launchpad / Maharashtra / Mumbai / National / Pharma / Singapore / World
Sun Pharma launches Tedizolid Phosphate tablets 200 mg in India for skin diseases
It is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI) The […]
America / Breaking News / Business / Launchpad / Maharashtra / Mumbai / National / New York / Pharma / Washington
US FDA approves LEQSELVI, an Oral JAK Inhibitor for treatment of severe Alopecia Areata
LEQSELVI delivered statistically significant efficacy across two Phase 3 clinical trials At baseline, the average patient had only […]